A risk classification model for prioritising the management of quality issues relating to substandard medicines in Singapore.
Pei San AngDesmond Chun Hwee TeoYi Long TohMichelle Sau Yuen NgChih Tzer ChoongDoris Sock Tin PhuahDorothy Hooi Myn TanFilina Meixuan TanMaggie Siok Hwee TanSuan Tian KohWint Maw ThinnJalene Wang Woon PohSreemanee Raaj DorajooPublished in: Pharmacoepidemiology and drug safety (2022)
This study reported characteristics that predicts cases with high impact, and the use of a statistical model to identify such cases. The model may potentially be applied to prioritise product defect issues and strengthen overall surveillance efforts of substandard medicines.
Keyphrases